MLL-r leukemia is characterised by deregulated gene expression that reportedly entails increased expression levels of HOXA9, MEIS1, CMYC and BCL2, which have been suggested to play important roles in MLL-r leukemia cell survival [44–46]. Here, BCL2 is linked to leukemia.